Annette Altmann

7.8k total citations · 5 hit papers
90 papers, 5.8k citations indexed

About

Annette Altmann is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Annette Altmann has authored 90 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 37 papers in Oncology and 31 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Annette Altmann's work include Peptidase Inhibition and Analysis (24 papers), Monoclonal and Polyclonal Antibodies Research (22 papers) and Cancer, Hypoxia, and Metabolism (21 papers). Annette Altmann is often cited by papers focused on Peptidase Inhibition and Analysis (24 papers), Monoclonal and Polyclonal Antibodies Research (22 papers) and Cancer, Hypoxia, and Metabolism (21 papers). Annette Altmann collaborates with scholars based in Germany, United States and France. Annette Altmann's co-authors include Uwe Haberkorn, Walter Mier, Jürgen Debus, Thomas Lindner, Clemens Kratochwil, Frederik L. Giesel, Anastasia Loktev, Dirk Jäger, Paul Flechsig and Frederik Marmé and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Oncogene.

In The Last Decade

Annette Altmann

90 papers receiving 5.8k citations

Hit Papers

68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of ... 2018 2026 2020 2023 2019 2018 2018 2018 2019 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
    2019 964 citations Clemens Kratochwil, Paul Flechsig et al. Journal of Nuclear Medicine profile →
  2. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein
    2018 644 citations Thomas Lindner, Anastasia Loktev et al. Journal of Nuclear Medicine profile →
  3. A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts
    2018 534 citations Anastasia Loktev, Thomas Lindner et al. Journal of Nuclear Medicine profile →
  4. 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
    2018 488 citations Frederik L. Giesel, Clemens Kratochwil et al. Journal of Nuclear Medicine profile →
  5. Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention
    2019 370 citations Anastasia Loktev, Thomas Lindner et al. Journal of Nuclear Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annette Altmann Germany 33 3.9k 2.1k 1.8k 1.7k 1.5k 90 5.8k
Dirk Jäger Germany 35 3.5k 0.9× 1.3k 0.6× 1.4k 0.8× 1.2k 0.7× 1.7k 1.1× 120 5.9k
Frederik Marmé Germany 36 4.3k 1.1× 2.7k 1.3× 934 0.5× 840 0.5× 2.1k 1.3× 236 6.6k
Ruth Holm Norway 45 2.8k 0.7× 1.3k 0.6× 873 0.5× 250 0.1× 2.8k 1.8× 187 6.1k
Martina Mirlacher Switzerland 39 2.5k 0.6× 1.1k 0.5× 656 0.4× 816 0.5× 2.2k 1.4× 62 5.3k
Haojun Chen China 32 2.7k 0.7× 1.4k 0.7× 1.4k 0.8× 1.1k 0.7× 629 0.4× 135 3.7k
Roland Haubner Germany 45 2.0k 0.5× 850 0.4× 312 0.2× 3.8k 2.2× 2.7k 1.8× 93 7.3k
Sebastian Adeberg Germany 33 2.2k 0.6× 1.0k 0.5× 1.3k 0.7× 1.1k 0.6× 450 0.3× 165 4.2k
R. Katherine Alpaugh United States 37 2.6k 0.7× 859 0.4× 314 0.2× 996 0.6× 1.7k 1.1× 112 4.5k
Johanna Lahdenranta United States 23 1.4k 0.4× 618 0.3× 247 0.1× 823 0.5× 2.0k 1.3× 51 3.6k
Andrea T. Hooper United States 32 2.6k 0.7× 1.2k 0.6× 298 0.2× 475 0.3× 2.8k 1.8× 56 5.8k

Countries citing papers authored by Annette Altmann

Since Specialization
Citations

This map shows the geographic impact of Annette Altmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Altmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Altmann more than expected).

Fields of papers citing papers by Annette Altmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Altmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Altmann. The network helps show where Annette Altmann may publish in the future.

Co-authorship network of co-authors of Annette Altmann

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Altmann. A scholar is included among the top collaborators of Annette Altmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Altmann. Annette Altmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haberkorn, Uwe, Annette Altmann, Frederik L. Giesel, & Clemens Kratochwil. (2024). 1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?. Journal of Nuclear Medicine. 65(10). 1518–1520. 5 indexed citations
2.
Altmann, Annette, Clemens Kratochwil, Frederik L. Giesel, & Uwe Haberkorn. (2021). Ligand engineering for theranostic applications. Current Opinion in Chemical Biology. 63. 145–151. 6 indexed citations
3.
Altmann, Annette, Uwe Haberkorn, & Jens T. Siveke. (2020). The Latest Developments in Imaging of Fibroblast Activation Protein. Journal of Nuclear Medicine. 62(2). 160–167. 180 indexed citations
4.
Röhrich, Manuel, Anastasia Loktev, Annika K. Wefers, et al.. (2019). IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein–specific PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 46(12). 2569–2580. 110 indexed citations
5.
Roesch, Saskia, Thomas Lindner, Max Sauter, et al.. (2018). Comparison of the RGD Motif–Containing αvβ6Integrin–Binding Peptides SFLAP3 and SFITGv6 for Diagnostic Application in HNSCC. Journal of Nuclear Medicine. 59(11). 1679–1685. 42 indexed citations
6.
Altmann, Annette, Max Sauter, Saskia Roesch, et al.. (2017). Identification of a Novel ITGαvβ6-Binding Peptide Using Protein Separation and Phage Display. Clinical Cancer Research. 23(15). 4170–4180. 45 indexed citations
7.
Zoller, Frederic, Annette Markert, Philippe Barthe, et al.. (2013). A Disulfide‐Constrained Miniprotein with Striking Tumor‐Binding Specificity Developed by Ribosome Display. Angewandte Chemie International Edition. 52(45). 11760–11764. 11 indexed citations
8.
Zoller, Frederic, Annette Markert, Philippe Barthe, et al.. (2012). Combination of Phage Display and Molecular Grafting Generates Highly Specific Tumor‐Targeting Miniproteins. Angewandte Chemie International Edition. 51(52). 13136–13139. 36 indexed citations
9.
Askoxylakis, Vasileios, Gunda Millonig, Ute Wirkner, et al.. (2011). Investigation of tumor hypoxia using a two-enzyme system for in vitro generation of oxygen deficiency. Radiation Oncology. 6(1). 35–35. 17 indexed citations
10.
Haberkorn, Uwe, Michael Eisenhut, Annette Altmann, & Walter Mier. (2009). Molecular endoradiotherapy of cancer. 21(1). 5–19. 1 indexed citations
11.
Zitzmann-Kolbe, Sabine, Susanne Krämer, Christel Herold‐Mende, et al.. (2009). Identification and Characterization of a Peptide with Affinity to Head and Neck Cancer. Journal of Nuclear Medicine. 50(3). 426–434. 37 indexed citations
12.
Haberkorn, Uwe, Johannes Hoffend, Kerstin Schmidt, et al.. (2007). Changes in glucose metabolism and gene expression after transfer of anti-angiogenic genes in rat hepatoma. European Journal of Nuclear Medicine and Molecular Imaging. 34(12). 2011–2023. 5 indexed citations
13.
Chen, Libo, Annette Altmann, Walter Mier, et al.. (2006). Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene.. PubMed. 47(5). 854–62. 42 indexed citations
14.
Haberkorn, Uwe, W Kübler, Michael Eisenhut, et al.. (2004). Iodide kinetics and dosimetry in vivo after transfer of the human sodium iodide symporter gene in rat thyroid carcinoma cells.. PubMed. 45(5). 827–33. 16 indexed citations
15.
Haberkorn, Uwe & Annette Altmann. (2003). Functional genomics and radioisotope-based imaging procedures. Annals of Medicine. 35(6). 370–379. 4 indexed citations
16.
Jiang, Shiming, Jürgen A. Kleinschmidt, Frank Schönsiegel, et al.. (2003). Tumor-specific gene expression using regulatory elements of the glucose transporter isoform 1 gene. Cancer Gene Therapy. 11(1). 41–51. 12 indexed citations
17.
Haberkorn, Uwe, Marcus Henze, Annette Altmann, et al.. (2001). Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells.. PubMed. 42(2). 317–25. 90 indexed citations
18.
Jiang, Shiming, Annette Altmann, Dirk Grimm, et al.. (2001). Tissue-specific gene expression in medullary thyroid carcinoma cells employing calcitonin regulatory elements and AAV vectors. Cancer Gene Therapy. 8(7). 469–472. 18 indexed citations
19.
Gissmann, Lutz, Annette Altmann, Frank Momburg, et al.. (1996). Human papillomavirus type 16 (HPV 16) E7 and major histocompatibility complex (MHC) class I and II expression in human keratinocytes in culture. Archives of Virology. 141(3-4). 449–458. 5 indexed citations
20.
Jochmus, Ingrid, Matthias Dürst, Richard J. Reid, et al.. (1993). Major histocompatibility complex and human papillomavirus type 16 E7 expression in high-grade vulvar lesions. Human Pathology. 24(5). 519–524. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dirk Jäger Breakdown of academic impact, for papers by Frederik Marmé Breakdown of academic impact, for papers by Ruth Holm Breakdown of academic impact, for papers by Martina Mirlacher Breakdown of academic impact, for papers by Haojun Chen Breakdown of academic impact, for papers by Roland Haubner Breakdown of academic impact, for papers by Sebastian Adeberg Breakdown of academic impact, for papers by R. Katherine Alpaugh Breakdown of academic impact, for papers by Johanna Lahdenranta Breakdown of academic impact, for papers by Andrea T. Hooper
Rankless by CCL
2026